Workflow
尔康制药:2025年上半年净利润3763.46万元,同比增长497.36%

Core Insights - The company Erkang Pharmaceutical (300267) reported a revenue of 682 million yuan for the first half of 2025, representing a year-on-year growth of 9.74% [1] - The net profit for the same period reached 37.6346 million yuan, showing a significant year-on-year increase of 497.36% [1] - The basic earnings per share (EPS) stood at 0.0182 yuan, with a weighted average return on equity (ROE) of 0.85% [1]